DNAJC10 and neoplasm: Strikingly, DNAJC10-OE A172 xenografts displayed significantly reduced tumor infiltration and prolonged survival (Fig. S6) compared to Vector controls, mirroring results from wild-type EGFR-expressing U87 models.